SOHM, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHMN research report →
About the company
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products.
- CEO
- Baron Night
- IPO
- 2010
- Employees
- 17
- HQ
- Corona, CA, US
Price Chart
- Market Cap
- $1.58M
- P/E
- 3.33
- P/S
- 1.34
- P/B
- 0.75
- EV/EBITDA
- -8.32
- Div Yield
- 0.00%
- Gross Margin
- 74.53%
- Op Margin
- -42.84%
- Net Margin
- -42.96%
- ROE
- -46.81%
- ROIC
- -7.75%
- Revenue
- $1.18M · 24.22%
- Net Income
- $-506,484 · 16.68%
- EPS
- $0.00 · 166.67%
- Op Income
- $-505,036
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.79
- Avg Volume
- 1.66M
Get TickerSpark's AI analysis on SHMN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SHMN coverage
Recent articles, reports, and earnings notes.
No research on SHMN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHMN report →Similar companies
Peers in the same neighborhood.